Press Release

IP Infusion Advances AI Data Center Networking with Ethernet-based Disaggregated Solution

Partners with HYPER SCALERS to Deploy Agile, Cost-Efficient Networks for GPU-intensive AI Workloads.

Santa Clara, CA – July 9, 2025 – IP Infusion, a global leader in open networking solutions, today announced the release of OcNOS® Data Center (OcNOS-DC) 6.6.1, the industry's most widely deployed disaggregated networking software specifically designed to support the demanding requirements of artificial intelligence (AI) and machine learning (ML) workloads. Built to run on Broadcom's Tomahawk 5 chipset, OcNOS-DC 6.6.1 powers high-performance, low-latency Ethernet-based AI data center fabrics on ONIE-enabled Edgecore AS9817-64D and UfiSpace S9321-64E white-box switches with 51.2Tbps switching capacity.

As AI training clusters scale exponentially, traditional networking solutions struggle to handle the intensive east-west traffic patterns and stringent latency and packet loss requirements of distributed GPU workloads. OcNOS-DC 6.6.1 addresses these challenges with advanced features, including Priority-based Flow Control (PFC) over Layer 3, Enhanced Transmission Selection (ETS), Data Center Bridging Capabilities Exchange Protocol (DCBX), and Dynamic Load Balancing (DLB). These capabilities work cohesively to deliver high-throughput, lossless connectivity, which is critical for AI-driven networks.

OcNOS-DC 6.6.1 enhances AI workload orchestration by exporting real-time gNMI telemetry to orchestrators like Kubernetes, enabling dynamic job allocation and reallocation when network paths are overloaded. Integration with Ansible further automates the reservation of lossless queues, priority-to-traffic-class mapping, and activation of dynamic load balancing on job-specific links, optimizing GPU server rack performance.

By leveraging disaggregated open networking, OcNOS-DC 6.6.1 offers cost-effective scaling, flexibility in optics selection, and agile data center buildouts through competitive bidding and component-level price tracking.

"OcNOS Data Center sets a new standard for AI networking, delivering unparalleled performance and scalability for next-generation data centers," said Kiyo Oishi, CEO of IP Infusion. "By combining Broadcom's Tomahawk 5 chipset with our advanced software features, we're enabling customers like HYPER SCALERS to build agile, cost-efficient networks that meet the rigorous demands of GPU-intensive AI workloads."

"Partnering with IP Infusion to deploy OcNOS-DC 6.6.1 has revolutionized our ability to deliver high-performance GPU-based services," said George Cvetanovski, Founder and CEO of HYPER SCALERS. "The AI-optimized features, seamless orchestration integration, and disaggregated architecture allow us to scale efficiently while maintaining the low-latency, lossless connectivity our customers require for their AI workloads."

Availability

For more information, visit IP Infusion's website or contact ipisales@ipinfusion.com.

关于 IP Infusion

IP Infusion develops open network software solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion leads the market in Network Operating Systems. Its flagship platform, OcNOS®, empowers network operators to disaggregate their networks, streamline operations, and reduce total cost of ownership (TCO). Headquartered in Santa Clara, Calif., IP Infusion is a wholly owned subsidiary of ACCESS CO., LTD. For more information, visit www.ipinfusion.com/. 

媒体联系

Katherine Verducci, 1903 PR
kverducci@1903pr.com
408.429.5779

关于 IP Infusion

IP Infusion 是开放网络软件的领先供应商,提供面向服务提供商、数据中心和 AI Fabric 网络的运营商级网络操作系统 OcNOS。凭借自 1999 年以来的网络技术积累和全球 600+ 家运营商的部署,IP Infusion 在 Edgecore Networks、UfiSpace 和 Celestica 等合作伙伴经过验证的开放硬件上,实现开放、多厂商、高性价比且灵活的网络基础设施。IP Infusion 是 ACCESS CO., LTD.(东京证券交易所:4813)的全资子公司。

媒体联系

For press inquiries, analyst briefings, or media materials, please 联系我们团队 or email pr@ipinfusion.com.

前瞻性陈述

本新闻稿可能包含有关 IP Infusion 产品、技术和计划的前瞻性陈述。前瞻性陈述基于发布之日可获得的信息,涉及风险和不确定性,实际结果可能存在差异。产品计划、功能、发布时间和供应情况可能随时变更,恕不另行通知,且不构成任何承诺、保证或法律义务。IP Infusion 不承担更新任何前瞻性陈述的义务。